86 related articles for article (PubMed ID: 18923503)
1. Cancer: A ringleader identified.
Eng C
Nature; 2008 Oct; 455(7215):883-4. PubMed ID: 18923503
[No Abstract] [Full Text] [Related]
2. Identification of ALK as a major familial neuroblastoma predisposition gene.
Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
[TBL] [Abstract][Full Text] [Related]
3. [Discovery of a gene mutation associated with familial neuroblastoma].
Nau JY
Rev Med Suisse; 2008 Sep; 4(169):1888. PubMed ID: 18831412
[No Abstract] [Full Text] [Related]
4. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
5. Germline PHOX2B mutation in hereditary neuroblastoma.
Mosse YP; Laudenslager M; Khazi D; Carlisle AJ; Winter CL; Rappaport E; Maris JM
Am J Hum Genet; 2004 Oct; 75(4):727-30. PubMed ID: 15338462
[No Abstract] [Full Text] [Related]
6. Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK?
Morgenstern DA; Soh SY; Stavropoulos DJ; Bowdin S; Baruchel S; Malkin D; Meyn MS; Irwin MS
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e193-6. PubMed ID: 24276038
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic mutations of ALK kinase in neuroblastoma.
Chen Y; Takita J; Choi YL; Kato M; Ohira M; Sanada M; Wang L; Soda M; Kikuchi A; Igarashi T; Nakagawara A; Hayashi Y; Mano H; Ogawa S
Nature; 2008 Oct; 455(7215):971-4. PubMed ID: 18923524
[TBL] [Abstract][Full Text] [Related]
8. Biological role of anaplastic lymphoma kinase in neuroblastoma.
Osajima-Hakomori Y; Miyake I; Ohira M; Nakagawara A; Nakagawa A; Sakai R
Am J Pathol; 2005 Jul; 167(1):213-22. PubMed ID: 15972965
[TBL] [Abstract][Full Text] [Related]
9. Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.
Passoni L; Longo L; Collini P; Coluccia AM; Bozzi F; Podda M; Gregorio A; Gambini C; Garaventa A; Pistoia V; Del Grosso F; Tonini GP; Cheng M; Gambacorti-Passerini C; Anichini A; Fossati-Bellani F; Di Nicola M; Luksch R
Cancer Res; 2009 Sep; 69(18):7338-46. PubMed ID: 19723661
[TBL] [Abstract][Full Text] [Related]
10. Activating mutations in ALK provide a therapeutic target in neuroblastoma.
George RE; Sanda T; Hanna M; Fröhling S; Luther W; Zhang J; Ahn Y; Zhou W; London WB; McGrady P; Xue L; Zozulya S; Gregor VE; Webb TR; Gray NS; Gilliland DG; Diller L; Greulich H; Morris SW; Meyerson M; Look AT
Nature; 2008 Oct; 455(7215):975-8. PubMed ID: 18923525
[TBL] [Abstract][Full Text] [Related]
11. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
12. Assignment of protooncogene MERTK (a.k.a. c-mer) to human chromosome 2q14.1 by in situ hybridization.
Weier HU; Fung J; Lersch RA
Cytogenet Cell Genet; 1999; 84(1-2):91-2. PubMed ID: 10343112
[No Abstract] [Full Text] [Related]
13. [ALK, a key gene in the pathogenesis of neuroblastoma].
Janoueix-Lerosey I; Delattre O
Med Sci (Paris); 2009 Apr; 25(4):330-2. PubMed ID: 19409178
[No Abstract] [Full Text] [Related]
14. Revisiting tissue specificity of germline cancer predisposing mutations.
Maris JM; Knudson AG
Nat Rev Cancer; 2015 Feb; 15(2):65-6. PubMed ID: 25688405
[TBL] [Abstract][Full Text] [Related]
15. New germline syndrome with brainstem abnormalities and neuroblastoma, caused by ALK mutation.
Wilkie AO
Hum Mutat; 2011 Mar; 32(3):v. PubMed ID: 21972113
[No Abstract] [Full Text] [Related]
16. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract][Full Text] [Related]
17. Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
Maris JM; Kyemba SM; Rebbeck TR; White PS; Sulman EP; Jensen SJ; Allen C; Biegel JA; Yanofsky RA; Feldman GL; Brodeur GM
Cancer Res; 1996 Aug; 56(15):3421-5. PubMed ID: 8758905
[TBL] [Abstract][Full Text] [Related]
18. Effect of missense mutations on structure and interaction of anaplastic Lymphoma kinase (ALK) in neuroblastom.
Kanwal H; Khan MH; Rashid H
Pak J Pharm Sci; 2013 May; 26(3):611-6. PubMed ID: 23625438
[TBL] [Abstract][Full Text] [Related]
19. Expression of the ALK tyrosine kinase gene in neuroblastoma.
Lamant L; Pulford K; Bischof D; Morris SW; Mason DY; Delsol G; Mariamé B
Am J Pathol; 2000 May; 156(5):1711-21. PubMed ID: 10793082
[TBL] [Abstract][Full Text] [Related]
20. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.
Stock C; Bozsaky E; Watzinger F; Poetschger U; Orel L; Lion T; Kowalska A; Ambros PF
Am J Pathol; 2008 Jan; 172(1):203-14. PubMed ID: 18165268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]